1. Home
  2. YRD vs IMRX Comparison

YRD vs IMRX Comparison

Compare YRD & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yiren Digital Ltd.

YRD

Yiren Digital Ltd.

HOLD

Current Price

$3.60

Market Cap

321.4M

Sector

Finance

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.81

Market Cap

320.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YRD
IMRX
Founded
2012
2008
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
321.4M
320.3M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
YRD
IMRX
Price
$3.60
$4.81
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
34.6K
713.7K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
12.36%
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$1.10
52 Week High
$7.68
$10.08

Technical Indicators

Market Signals
Indicator
YRD
IMRX
Relative Strength Index (RSI) 40.98 41.94
Support Level $3.58 $4.49
Resistance Level $3.98 $5.36
Average True Range (ATR) 0.14 0.30
MACD -0.01 -0.03
Stochastic Oscillator 19.15 9.57

Price Performance

Historical Comparison
YRD
IMRX

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: